ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/13 | 970 | 974 | 890 | 929 | -19 | -2% | 3,428,000 |
2018/12/12 | 923 | 968 | 910 | 948 | +36 | +3.9% | 1,270,900 |
2018/12/11 | 940 | 958 | 903 | 912 | -16 | -1.7% | 1,201,300 |
2018/12/10 | 951 | 953 | 915 | 928 | -38 | -3.9% | 1,320,400 |
2018/12/07 | 987 | 1,003 | 960 | 966 | -11 | -1.1% | 1,152,700 |
2018/12/06 | 1,000 | 1,005 | 968 | 977 | -32 | -3.2% | 1,404,300 |
2018/12/05 | 1,030 | 1,044 | 1,004 | 1,009 | -51 | -4.8% | 1,423,800 |
2018/12/04 | 1,088 | 1,123 | 1,048 | 1,060 | -40 | -3.6% | 1,461,700 |
2018/12/03 | 1,130 | 1,163 | 1,097 | 1,100 | -5 | -0.5% | 2,100,600 |
2018/11/30 | 1,101 | 1,132 | 1,089 | 1,105 | +15 | +1.4% | 1,202,100 |
2018/11/29 | 1,129 | 1,137 | 1,085 | 1,090 | -18 | -1.6% | 1,450,300 |
2018/11/28 | 1,070 | 1,129 | 1,066 | 1,108 | +43 | +4% | 1,593,700 |
2018/11/27 | 1,062 | 1,103 | 1,055 | 1,065 | +13 | +1.2% | 1,366,200 |
2018/11/26 | 1,060 | 1,074 | 1,046 | 1,052 | -8 | -0.8% | 710,100 |
2018/11/22 | 1,050 | 1,077 | 1,041 | 1,060 | +13 | +1.2% | 796,900 |
2018/11/21 | 1,032 | 1,083 | 1,027 | 1,047 | +5 | +0.5% | 993,700 |
2018/11/20 | 1,080 | 1,083 | 1,036 | 1,042 | -56 | -5.1% | 1,559,500 |
2018/11/19 | 1,028 | 1,123 | 1,028 | 1,098 | +59 | +5.7% | 1,947,200 |
2018/11/16 | 1,081 | 1,091 | 1,036 | 1,039 | -15 | -1.4% | 1,100,100 |
2018/11/15 | 1,026 | 1,077 | 1,023 | 1,054 | +17 | +1.6% | 1,300,500 |
2018/11/14 | 1,047 | 1,073 | 1,019 | 1,037 | -12 | -1.1% | 1,059,700 |
2018/11/13 | 1,003 | 1,058 | 987 | 1,049 | +16 | +1.5% | 1,887,400 |
2018/11/12 | 1,165 | 1,185 | 1,026 | 1,033 | -102 | -9% | 4,769,700 |
2018/11/09 | 1,023 | 1,135 | 1,023 | 1,135 | +150 | +15.2% | 5,425,400 |
2018/11/08 | 1,010 | 1,018 | 978 | 985 | +13 | +1.3% | 1,293,200 |
2018/11/07 | 965 | 997 | 953 | 972 | -7 | -0.7% | 1,546,100 |
2018/11/06 | 958 | 983 | 942 | 979 | +23 | +2.4% | 1,350,000 |
2018/11/05 | 920 | 983 | 918 | 956 | +21 | +2.2% | 1,438,600 |
2018/11/02 | 911 | 954 | 911 | 935 | +58 | +6.6% | 2,400,900 |
2018/11/01 | 862 | 883 | 844 | 877 | ±0 | ±0% | 1,891,400 |
2018/10/31 | 880 | 895 | 857 | 877 | +12 | +1.4% | 1,904,300 |
2018/10/30 | 841 | 878 | 835 | 865 | +23 | +2.7% | 2,443,100 |
2018/10/29 | 873 | 901 | 841 | 842 | -36 | -4.1% | 2,474,300 |
2018/10/26 | 924 | 936 | 844 | 878 | -32 | -3.5% | 4,090,000 |
2018/10/25 | 946 | 949 | 905 | 910 | -77 | -7.8% | 3,542,800 |
2018/10/24 | 1,021 | 1,027 | 978 | 987 | -20 | -2% | 1,771,600 |
2018/10/23 | 1,035 | 1,035 | 998 | 1,007 | -32 | -3.1% | 1,419,000 |
2018/10/22 | 1,010 | 1,044 | 1,005 | 1,039 | +17 | +1.7% | 1,853,200 |
2018/10/19 | 1,054 | 1,062 | 1,021 | 1,022 | -53 | -4.9% | 2,743,100 |
2018/10/18 | 1,110 | 1,120 | 1,071 | 1,075 | -46 | -4.1% | 1,909,900 |
2018/10/17 | 1,142 | 1,159 | 1,112 | 1,121 | -1 | -0.1% | 1,725,900 |
2018/10/16 | 1,115 | 1,136 | 1,096 | 1,122 | +35 | +3.2% | 1,100,300 |
2018/10/15 | 1,125 | 1,132 | 1,085 | 1,087 | -50 | -4.4% | 1,295,700 |
2018/10/12 | 1,099 | 1,145 | 1,090 | 1,137 | +51 | +4.7% | 1,592,400 |
2018/10/11 | 1,032 | 1,108 | 1,030 | 1,086 | -36 | -3.2% | 1,883,700 |
2018/10/10 | 1,123 | 1,136 | 1,092 | 1,122 | +21 | +1.9% | 1,800,700 |
2018/10/09 | 1,169 | 1,173 | 1,092 | 1,101 | -95 | -7.9% | 3,346,200 |
2018/10/05 | 1,212 | 1,237 | 1,184 | 1,196 | -22 | -1.8% | 1,787,200 |
2018/10/04 | 1,253 | 1,268 | 1,210 | 1,218 | -62 | -4.8% | 2,617,300 |
2018/10/03 | 1,309 | 1,320 | 1,278 | 1,280 | -32 | -2.4% | 1,656,900 |
1601~
1650
件表示中 / 5129件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 87,300円 | +20.3% | - | 0.00% | 154.79倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 288,100円 | +5.1% | -7.0% | 2.78% | 18.91倍 | 0.78倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | -2.4% | -52.3% | 3.84% | 17.79倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 203,700円 | +4.1% | -3.1% | 2.85% | 17.66倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 59,400円 | +14.3% | - | 3.37% | 24.13倍 | 1.54倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム